Display options
Cite
Miglietta G, Gouda AS, Cogoi S, et al. Nucleic Acid Targeted Therapy: G4 Oligonucleotides Downregulate HRAS in Bladder Cancer Cells through a Decoy Mechanism. ACS Med Chem Lett. 2015;6(12):1179-83doi: 10.1021/acsmedchemlett.5b00315.
Miglietta, G., Gouda, A. S., Cogoi, S., Pedersen, E. B., & Xodo, L. E. (2015). Nucleic Acid Targeted Therapy: G4 Oligonucleotides Downregulate HRAS in Bladder Cancer Cells through a Decoy Mechanism. ACS medicinal chemistry letters, 6(12), 1179-83. https://doi.org/10.1021/acsmedchemlett.5b00315
Miglietta, Giulia, et al. "Nucleic Acid Targeted Therapy: G4 Oligonucleotides Downregulate HRAS in Bladder Cancer Cells through a Decoy Mechanism." ACS medicinal chemistry letters vol. 6,12 (2015): 1179-83. doi: https://doi.org/10.1021/acsmedchemlett.5b00315
Miglietta G, Gouda AS, Cogoi S, Pedersen EB, Xodo LE. Nucleic Acid Targeted Therapy: G4 Oligonucleotides Downregulate HRAS in Bladder Cancer Cells through a Decoy Mechanism. ACS Med Chem Lett. 2015 Oct 18;6(12):1179-83. doi: 10.1021/acsmedchemlett.5b00315. eCollection 2015 Dec 10. PMID: 26713101; PMCID: PMC4677363.
Copy Download .nbib Format: NLM
Share it on

ACS Med Chem Lett. 2015 Oct 18;6(12):1179-83. doi: 10.1021/acsmedchemlett.5b00315. eCollection 2015 Dec 10.

Nucleic Acid Targeted Therapy: G4 Oligonucleotides Downregulate HRAS in Bladder Cancer Cells through a Decoy Mechanism.

ACS medicinal chemistry letters

Giulia Miglietta, Alaa S Gouda, Susanna Cogoi, Erik B Pedersen, Luigi E Xodo

Affiliations

  1. Department of Medical and Biological Sciences, University of Udine , 33100 Udine, Italy.
  2. Nucleic Acid Center, Institute of Physics and Chemistry, University of Southern Denmark , DK-5230 Odense M, Denmark.

PMID: 26713101 PMCID: PMC4677363 DOI: 10.1021/acsmedchemlett.5b00315

Abstract

In a previous study we have demonstrated that two neighboring G-quadruplexes, hras-1 and hras-2, located immediately upstream of the major transcription start site of HRAS, bind MAZ, a nuclear factor that activates transcription (Cogoi, S.; et al. Nucl. Acid Res. 2014, 42, 8379). For the present study we have designed G4 oligonucleotides with anthraquinone insertions and locked nucleic acids (LNA) modifications mimicking quadruplex hras-1. Luciferase, qRT-PCR, and Western blot data demonstrate that these constructs efficiently down regulate HRAS in T24 bladder cancer cells. The inhibitory efficiency of the G4 oligonucleotides correlates with their nuclease resistance in the cell environment. By chromatin immunoprecipitation we show that the association of MAZ to the HRAS promoter is strongly attenuated by the designed G4 oligonucleotides, thus suggesting that these constructs behave with a decoy mechanism.

Keywords: G4-oligonucleotides; HRAS; T24 bladder cancer cells; anthraquinone insertions; decoy mechanism

References

  1. Cancer Lett. 1996 Oct 22;107(2):241-7 - PubMed
  2. Methods Mol Biol. 2015;1317:167-83 - PubMed
  3. Org Biomol Chem. 2006 Nov 7;4(21):4015-21 - PubMed
  4. Nat Rev Cancer. 2007 Apr;7(4):295-308 - PubMed
  5. PLoS One. 2011;6(9):e24421 - PubMed
  6. J Clin Invest. 2007 Feb;117(2):314-25 - PubMed
  7. Nucleic Acids Res. 2014 Jul;42(13):8379-88 - PubMed
  8. Nucleic Acids Res. 2013 Apr;41(7):4049-64 - PubMed
  9. Top Curr Chem. 2013;330:67-86 - PubMed
  10. Oncogene. 1998 Sep 17;17(11 Reviews):1343-52 - PubMed
  11. Hum Gene Ther. 2014 Aug;25(8):721-9 - PubMed
  12. J Clin Invest. 2004 Sep;114(5):720-8 - PubMed
  13. Mol Med. 2014 Mar 18;20:46-56 - PubMed
  14. EMBO Mol Med. 2011 Nov;3(11):623-36 - PubMed
  15. J Mol Med (Berl). 2013 May;91(5):573-86 - PubMed
  16. Biophys Chem. 2005 Feb 1;113(2):155-60 - PubMed
  17. Proc Natl Acad Sci U S A. 1990 Nov;87(22):9047-51 - PubMed
  18. Curr Oncol. 2011 Jan;18(1):e25-34 - PubMed
  19. Cell. 2012 Apr 27;149(3):656-70 - PubMed
  20. Nature. 2008 Oct 23;455(7216):1069-75 - PubMed
  21. Anal Sci. 2007 Mar;23(3):249-51 - PubMed
  22. Eur J Pharm Biopharm. 2008 Sep;70(1):7-18 - PubMed
  23. Chem Soc Rev. 2011 Dec;40(12):5680-9 - PubMed
  24. Future Med Chem. 2011 Oct;3(14):1787-808 - PubMed

Publication Types